HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Exploring protein kinase inhibitors: potentiating gemcitabine efficacy in pancreatic cancer.

AuthorsYoung Bin Hong, Jung Soon Kim, Yong Weon Yi, Yeon-Sun Seong, Insoo Bae
JournalPancreas (Pancreas) Vol. 41 Issue 3 Pg. 496-8 (Apr 2012) ISSN: 1536-4828 [Electronic] United States
PMID22415672 (Publication Type: Letter, Research Support, Non-U.S. Gov't)
Chemical References
  • Antimetabolites, Antineoplastic
  • Protein Kinase Inhibitors
  • Deoxycytidine
  • Gemcitabine
Topics
  • Antimetabolites, Antineoplastic (pharmacology)
  • Antineoplastic Combined Chemotherapy Protocols (pharmacology)
  • Carcinoma, Pancreatic Ductal (enzymology, pathology)
  • Cell Line, Tumor
  • Cell Survival (drug effects)
  • Deoxycytidine (analogs & derivatives, pharmacology)
  • Dose-Response Relationship, Drug
  • Drug Resistance, Neoplasm
  • Drug Synergism
  • Humans
  • Inhibitory Concentration 50
  • Molecular Targeted Therapy
  • Pancreatic Neoplasms (enzymology, pathology)
  • Protein Kinase Inhibitors (pharmacology)
  • Gemcitabine

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: